Verse Therapy was acquired by Beaming Health.
SourceConnecting All Ages with Speech Language Pathologists
Public company, workplace, funding, and market signals
Verse Therapy (also known as Hona AI) was a San Francisco-based digital health / home health care company that helped speech-language pathologists launch and grow independent practices by providing an AI-enabled back office, insurance support, scheduling, documentation, marketing, and billing services. The company also offered 1-on-1 virtual speech therapy for children and adults and was acquired by Beaming Health in January 2026.
Primary product
AI-enabled back-office and practice-management platform for speech-language pathologists, paired with virtual speech therapy services
Founded
2024
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Work style
Remote
Industry
Home Health Care Services
Sub-industry
5 jobs at Verse Therapy
Digital health / speech therapy
Offices
Business model
Stage
Seed
Total raised
$3.1M
Latest round
Seed · May 2024
Latest amount
$3M
Leadership
Co-founder & CEO
Founder & COO
Co-founder & CTO
Director of Clinical Operations
Head of Growth
Head of Clinical Operations / Care Coordination
Founder of Hesed Speech and Language, PLLC & Partner
Investors
The company emphasized empathy, integrity, personalization, encouragement, and transparency, with a mission-oriented culture focused on reducing therapist burnout and expanding access to care.
Work style
Remote
Compensation
Public provider-facing postings described compensation of about $90k-$200k annually or $80-$120/hour for speech-language pathologists, depending on role and market.
Benefits
Pricing
Pay-per-session; recurring sessions and initial evaluations start at $95; in-network copays are typically $0-$40; HSA/FSA accepted; superbills provided.
Differentiators
Technology
Customers
Competitors
LinkedIn · Jan 2026
Co-founder Danielle J. Yoesep announced the acquisition and thanked the founding team and core staff.
LinkedIn · Jan 2026
Verse co-founder Adam Steinle announced that Verse Therapy was acquired by Beaming Health.
PitchBook
PitchBook listed Verse Therapy as founded in 2024 and acquired by Beaming Health on 2025-12-12, with investors including 1984 Ventures, Orange Collective, Ripple Impact Investments, Valia Ventures, and Y Combinator.
Y Combinator
Y Combinator described Verse Therapy as a company helping speech-language pathologists launch and grow independent practices through an AI-enabled back office and noted it was live in 10 states with 35+ therapists.
Indexed.vc
Indexed.vc summarized Verse Therapy as a San Francisco-based digital health company founded in 2024 with reported seed funding and investors including 1984 Ventures, Orange Collective, Valia Ventures, and Y Combinator Continuity Fund.